Volume : 12, Issue : 06, June – 2025
Title:
THERAPEUTIC DRUG MONITORING: ROLE OF PHARM.D IN PRECISION MEDICINE
Authors :
Dr. S.Tharun Raj, Dr. Hasanurjaman Mollick, Mahjuba Parvin Noorani, Gummula Rashmika, Dr. Mohammad Aakheel Ruman, Dr.B. Mounika Bai and Dr. Sumanth Raj Pasunoori *
Abstract :
Therapeutic Drug Monitoring (TDM) is a critical clinical tool that ensures drug efficacy and safety, by ensuring that plasma drug concentrations are kept in the therapeutic window for each drug. At a time when precision medicine has been widely accepted as a mark of true individualized patient care, TDM remains a crucial procedure for treatment individualization on the basis of pharmacokinetic and pharmacodynamic variations. Pharm.D professionals of the future would be perfectly placed to head TDM services, given their clinical pharmacology knowledge and particular patient focus. Their involvement in dose adjustments, interprofessional collaboration, patient education, therapeutic optimization, and outcome enhancement will play an active role in decreasing drug-related adverse events. This review discusses the basics and applications of TDM, the integration of TDM into precision medicine, and the ever-expanding role of Pharm.D graduates across several clinical settings. It touches on advances in technology and training and highlights future directions, which should, in particular, improve personalized healthcare delivery in which Pharm.D professionals are actively engaged through TDM.
Keywords: Therapeutic Drug Monitoring (TDM), Precision Medicine, Pharm.D, Clinical Pharmacokinetics, Individualized Therapy, Drug Safety, Dose Optimization, Pharmacogenomics, Patient-Centered Care, Clinical Pharmacy Practice
Cite This Article:
Please cite this article in press Sumanth Raj Pasunoori et al ., Therapeutic Drug Monitoring: Role Of Pharm.D In Precision Medicine.., Indo Am. J. P. Sci, 2025; 12(07).
Number of Downloads : 10
References:
1. Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009 Mar;24(1):1-10
2. Cooney L, Loke YK, Golder S, Kirkham J, Jorgensen A, Sinha I, Hawcutt D. Overview of systematic reviews of therapeutic ranges: methodologies and recommendations for practice. BMC Med Res Methodol. 2017 Jun 2;17(1):84
3. Naithani N, Sinha S, Misra P, Vasudevan B, Sahu R. Precision medicine: Concept and tools. Med J Armed Forces India. 2021 Jul;77(3):249-257
4. Advani M, Seetharaman R, Pawar S, Mali S, Lokhande J. Past, present and future perspectives of therapeutic drug monitoring in India. Int J Clin Pract. 2021 Aug;75(8):e14189.
5. Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol. 2001;52(Suppl 1):5S–10S.
6. Widmer N, Csajka C, Werner D, Grouzmann E, Decosterd LA, Eap CB, Biollaz J, Buclin T. Suivi thérapeutique des médicaments (I). Les principes [Principles of therapeutic drug monitoring]. Rev Med Suisse. 2008 Jul 16;4(165):1644-8.
7. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012 Jul 26;16(4):R136.
8. Liang WS, Beaulieu-Jones B, Smalley S, Snyder M, Goetz LH, Schork NJ. Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine. Front Pharmacol. 2024 Mar 13;15:1348112.
9. Al Za’abi M, Al Muqbali J, Al-Waili K. Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman. Saudi Pharm J. 2015 Sep;23(4):458-62.
10. van der Kleij MBA, Guchelaar NAD, Meertens M, Westerdijk K, Giraud EL, Bleckman RF, Groenland SL, van Eerden RAG, Imholz ALT, Vulink AJE, Otten HM, Fiebrich-Westra HB, Lubberman FJE, Desar IME, Moes DAR, Touw DJ, Koolen SLW, Gelderblom H, Reyners AKL, van Erp NP, Mathijssen RHJ, Huitema ADR; Dutch Pharmacology Oncology Group (DPOG); Steeghs N. Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study. Br J Cancer. 2024 Sep;131(5):843-851
11. Biso L, Aringhieri S, Carli M, Scarselli M, Longoni B. Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Pharmaceuticals (Basel). 2024 May 16;17(5):642
12. Tyson RJ, Park CC, Powell JR, Patterson JH, Weiner D, Watkins PB, Gonzalez D. Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables. Front Pharmacol. 2020 Apr 22;11:420
13. Abdul-Aziz MH, Alffenaar JC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, Neely MN, Paiva JA, Pea F, Sjovall F, Timsit JF, Udy AA, Wicha SG, Zeitlinger M, De Waele JJ, Roberts JA; Infection Section of European Society of Intensive Care Medicine (ESICM); Pharmacokinetic/pharmacodynamic and Critically Ill Patient Study Groups of European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Infectious Diseases Group of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT); Infections in the ICU and Sepsis Working Group of International Society of Antimicrobial Chemotherapy (ISAC). Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. Intensive Care Med. 2020 Jun;46(6):1127-1153
14. Mohammadpour N, Elyasi S, Vahdati N, Mohammadpour AH, Shamsara J. A review on therapeutic drug monitoring of immunosuppressant drugs. Iran J Basic Med Sci. 2011 Nov;14(6):485-98
15. Lertsinudom S, Chaiyakum A, Tuntapakul S, Sawanyawisuth K, Tiamkao S, Tiamkao S; Integrated Epilepsy Research Group. Therapeutic drug monitoring in epilepsy clinic: a multi-disciplinary approach. Neurol Int. 2014 Dec 16;6(4):5620
16. Li X, Song Z, Yi Z, Qin J, Jiang D, Wang Z, Li H, Zhao R. Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review. Ther Adv Med Oncol. 2024 May 27;16:17588359241250130.
17. De Rose DU, Cairoli S, Dionisi M, Santisi A, Massenzi L, Goffredo BM, Dionisi-Vici C, Dotta A, Auriti C. Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. Int J Mol Sci. 2020 Aug 17;21(16):5898.
18. Cremers S, Guha N, Shine B. Therapeutic drug monitoring in the era of precision medicine: opportunities! Br J Clin Pharmacol. 2016 Oct;82(4):900-2.
19. Bardin C, Veal G, Paci A, Chatelut E, Astier A, Leveque D, et al. Therapeutic drug monitoring in cancer – are we missing a trick? Eur J Cancer 2014; 50: 2005–2009
20. Kahan BD, Keown P, Levy GA, Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther. 2002 Mar;24(3):330-50; discussion 329.
21. Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, Silva I, Magalhães P, Schmidt S, Vale N. Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics. 2024 Feb 27;16(3):332.
22. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, Zhao J, Snowdon JL. Precision Medicine, AI, and the Future of Personalized Health Care. Clin Transl Sci. 2021 Jan;14(1):86-93
23. Matysik F. Therapeutic Drug Monitoring: Enhancing Drug Safety and Efficacy. J Pharma Reports.2024; 08:229.
24. Weinshilboum RM, Wang L. Pharmacogenomics: Precision Medicine and Drug Response. Mayo Clin Proc. 2017 Nov;92(11):1711-1722.
25. Dodeja P, Chaphekar N, Caritis SN, Venkataramanan R. Optimizing drug therapy during pregnancy: a spotlight on population pharmacokinetic modeling. Expert Opin Drug Metab Toxicol. 2025 Jan-Feb;21(2):143-160
26. Liu Y, Li J, Xiao S, Liu Y, Bai M, Gong L, Zhao J, Chen D. Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy. Biosensors (Basel). 2023 Jul 12;13(7):726
27. Gonzalez D, Rao GG, Bailey SC, Brouwer KLR, Cao Y, Crona DJ, Kashuba ADM, Lee CR, Morbitzer K, Patterson JH, Wiltshire T, Easter J, Savage SW, Powell JR. Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact. Clin Transl Sci. 2017 Nov;10(6):443-454
28. Aghili M, Kasturirangan MN. Management of Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist’s Interventions. Indian J Crit Care Med. 2021 Nov;25(11):1226-1231.
29. Begg EJ, Chin PK. A unified pharmacokinetic approach to individualized drug dosing. Br J Clin Pharmacol. 2012 Mar;73(3):335-9
30. Mladěnka P, Applová L, Patočka J, Costa VM, Remiao F, Pourová J, Mladěnka A, Karlíčková J, Jahodář L, Vopršalová M, Varner KJ, Štěrba M; TOX-OER and CARDIOTOX Hradec Králové Researchers and Collaborators. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018 Jul;38(4):1332-1403.
31. Kobrai-Abkenar F, Salimi S, Pourghane P. “Interprofessional Collaboration” among Pharmacists, Physicians, and Nurses: A Hybrid Concept Analysis. Iran J Nurs Midwifery Res. 2024 Mar 26;29(2):238-244
32. Sanii Y, Torkamandi H, Gholami K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract. 2016 Apr-Jun;5(2):132-7.
33. Patel K, Chotai N. Documentation and Records: Harmonized GMP Requirements. J Young Pharm. 2011 Apr;3(2):138-50.
34. Barreto EF, Rule AD, Alshaer MH, Roberts JA, Abdul Aziz MH, Scheetz MH, Mara KC, Jannetto PJ, Gajic O, O’Horo JC, Boehmer KR. Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study. Implement Sci Commun. 2021 Mar 24;2(1):34
35. Sato Y, Kondo H, Sato Y, Abe A, Kikuchi M, Sato T, Kumondai M, Yoshikawa K, Hayakawa Y, Maekawa M, Mano N. Development of Simultaneous Drug Concentration Measurement Method Using an Automated Pretreatment Liquid Chromatography/Tandem Mass Spectrometry System for Therapeutic Drug Monitoring. Pharmaceutics. 2024 Aug 28;16(9):1138.
36. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020 Feb 6;3:17.
37. Brown JT, Bishop JR, Schneiderhan ME. Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management. Ment Health Clin. 2020 Jul 2;10(4):254-258.
38. Taloyan M, Jaranka A, Bidonde J, Flodgren G, Roberts NW, Hägglund M, Nilsson GH, Papachristou P. Remote digital monitoring for selected chronic diseases in primary health care. Cochrane Database Syst Rev. 2023 Mar 13;2023(3):CD015479
39. Oakley T, Vaz J, da Silva F, Allan R, Almeida D, Champlin K, da Silva ES, Tilman AJ, Marr I, Smith-Vaughan H, Yan J, Francis JR. Implementation of a Laboratory Information Management System (LIMS) for microbiology in Timor-Leste: challenges, mitigation strategies, and end-user experiences. BMC Med Inform Decis Mak. 2025 Jan 17;25(1):32
40. Papamichael K, Stocco G, Ruiz Del Agua A. Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases. Ther Drug Monit. 2023 Oct 1;45(5):579-590.
41. Voulgaridou G, Paraskeva T, Ragia G, Atzemian N, Portokallidou K, Kolios G, Arvanitidis K, Manolopoulos VG. Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years. Pharmaceutics. 2023 Aug 23;15(9):2181.
42. Maranchick NF, Peloquin CA. Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis. J Clin Tuberc Other Mycobact Dis. 2024 Apr 24;36:100444
43. Salman B, Al-Khabori M. Applications and challenges in therapeutic drug monitoring of cancer treatment: A review. J Oncol Pharm Pract. 2021 Apr;27(3):693-701.